Search

everythinglearnresearchcommunity

for

Search:↓

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

CT60 polymorphism might increase the risk of Alopecia Areata.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The study suggests that hypothyroidism may cause alopecia areata.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

New treatments targeting T-cell pathways are needed for better alopecia areata management.